Regulations.gov document
Draft Guidance for Industry on Liposome Drug Products: Chemistry, Manufacturing, and…
Other · FDA-2002-D-0093 · posted Oct 22, 2008
Key facts
| Document ID | FDA-2002-D-0093-0002 |
|---|---|
| Title | Draft Guidance for Industry on Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation; Draft Guidance Document |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2002-D-0093 |
| Posted | Oct 22, 2008 |
| Comment period opens | Oct 22, 2008 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: